Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/05/2011EP2371420A1 Veterinary pharmaceutical compositions for the treatment of pain and inflammation
10/05/2011EP2371379A2 New formulation for increasing bioavailability of neurturin
10/05/2011EP2371374A1 Soluble fiber from Musa spp. for treating gastroenteritis or diarrhea
10/05/2011EP2371371A2 Composition for preventing adhesion
10/05/2011EP2371370A1 Antagonists of miRNA-29 expression and their use in the prevention and treatment of aortic aneurysms and atherosclerotic plaque destabilization
10/05/2011EP2371369A1 EGFR inhibitor and antiviral agent for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of cancer
10/05/2011EP2371368A2 Compositions and methods for treatment of inflammation and hyperkeratotic lesions
10/05/2011EP2371367A1 Method of treating men with testosterone supplement and 5alpha reductase inhibitor
10/05/2011EP2371366A1 Heterocyclo inhibitors of potassium channel function
10/05/2011EP2371365A1 Compositions comprising an epothilone and production methods
10/05/2011EP2371364A1 Topical or intravenous co-enzyme Q10 formulations for use in treating cancer
10/05/2011EP2371363A1 Coenzyme Q10 formulations for use in the treatment of solid tumours
10/05/2011EP2371362A1 Co-enzyme Q10 formulations for treating cancer by intravenous administration
10/05/2011EP2371361A1 Methods to mobilize progenitor/stem cells
10/05/2011EP2371360A2 Selegiline-containing adhesive preparation
10/05/2011EP2371359A2 Selegiline-containing adhesive preparation
10/05/2011EP2371358A1 Film-form preparation and method for producing the same
10/05/2011EP2371357A1 Oral formulations and lipophilic salts of methylnaltrexone
10/05/2011EP2371356A1 Multi-particle pharmaceutical formulation for colon absorption
10/05/2011EP2371355A2 Preparations of phospholipids and pharmaceuticals containing-5-amino salicyclic acid for the treatment of inflammatory bowel disease
10/05/2011EP2371351A1 Pharmaceutical composition for the treatment of solar urticaria
10/05/2011EP2371350A1 Foam formulas for treating animal skin illnesses
10/05/2011EP2371219A1 Herbicidal acylhydrazides
10/05/2011EP2370593A2 Methods for the treatment of infections and tumors
10/05/2011EP2370582A2 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
10/05/2011EP2370581A2 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
10/05/2011EP2370578A1 RNA INTERFERENCE MEDIATED INHIBITION OF EPITHELIAL SODIUM CHANNEL (ENaC) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
10/05/2011EP2370577A2 Usirna complexes
10/05/2011EP2370568A1 Mek mutations conferring resistance to mek inhibitors
10/05/2011EP2370475A1 Production of a saccharide composition comprising glucans and mannans by alkaline and acid hydrolysis of yeast cells
10/05/2011EP2370474A1 Method to produce hyaluronic acid functionalized derivatives and formation of hydrogels thereof
10/05/2011EP2370447A1 Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
10/05/2011EP2370444A1 [4- (1-amino-ethyl) -cyclohexyl]-methyl-amines as antibacterials
10/05/2011EP2370443A1 Dihydroetorphines and their preparation
10/05/2011EP2370442A1 3-aminocyclopentanecarboxamides as chemokine receptor modulators
10/05/2011EP2370441A1 Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
10/05/2011EP2370440A1 Novel compounds
10/05/2011EP2370439A1 Lactams as beta secretase inhibitors
10/05/2011EP2370438A1 Imidazo [1,2a]pyridine derivatives, their use as s1p1 agonists and methods for their production
10/05/2011EP2370437A1 Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
10/05/2011EP2370436A1 Azaquinolinone derivatives and uses thereof
10/05/2011EP2370434A1 Corydaline derivatives useful for reducing lipid levels
10/05/2011EP2370431A1 1, 2, 4 -oxadiazole derivatives and their therapeutic use
10/05/2011EP2370430A1 N-(1-phenyl-2-arylethyl)-4,5-dihydro-3h-pyrrol-2-amine compounds as subtype selective modulators of alpha2b or alpha2b and alpha2c adrenoceptors
10/05/2011EP2370429A1 P38 map kinase inhibitors
10/05/2011EP2370428A1 P38 map kinase inhibitors
10/05/2011EP2370427A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and uses thereof
10/05/2011EP2370426A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and uses thereof
10/05/2011EP2370425A2 Fused imidazole derivatives as trpv3 antagonist
10/05/2011EP2370424A1 Compounds useful as inhibitors of atr kinase
10/05/2011EP2370422A1 Thiochromene derivatives as hip hydroxylase inhibitors
10/05/2011EP2370417A2 Lactate salt of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
10/05/2011EP2370416A1 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
10/05/2011EP2370415A2 Compositions and methods for inhibition of the jak pathway
10/05/2011EP2370414A2 Preparation of capecitabine
10/05/2011EP2370413A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/05/2011EP2370406A1 High penetration compositions and their applications
10/05/2011EP2370405A1 Triple reuptake inhibitors and methods of their use
10/05/2011EP2370402A2 Compounds for treating proliferative disorders
10/05/2011EP2370399A1 Glucose-peg conjugates for reducing glucose transport into a cell
10/05/2011EP2370396A2 Method for selectively crystallizing a z isomer of iopromide
10/05/2011EP2370390A2 Isolate compounds from phaleria macrocarpa as anti cancer
10/05/2011EP2370175A2 Methods of inhibiting quiescent tumor proliferation
10/05/2011EP2370109A1 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
10/05/2011EP2370097A1 Antitumor combinations containing antibodies recognizing specifically cd38 and cylophosphamide
10/05/2011EP2370096A1 Antitumor combinations containing antibodies recognizing specifically cd38 and cytarabine
10/05/2011EP2370095A1 Antitumor combinations containing antibodies recognizing specifically cd38 and vincristine
10/05/2011EP2370094A1 Antitumor combinations containing antibodies recognizing specifically cd38 and melphalan
10/05/2011EP2370091A2 Compositions and methods relating to mir-31
10/05/2011EP2370086A2 Methods and compositions for altering health, wellbeing, and lifespan
10/05/2011EP2370082A1 Drug composition cytotoxic for pancreatic cancer cells
10/05/2011EP2370081A1 Pharmaceutical compositions containing testosterone and an aromatase inhibitor
10/05/2011EP2370080A1 Pde1 as a target therapeutic in heart disease
10/05/2011EP2370079A2 Hsp90 inhibitors for therapeutic treatment
10/05/2011EP2370078A1 Method of optimizing the treatment of philadelphia-positive leukemia with imatinib mesylate
10/05/2011EP2370077A2 Method for treating macular degeneration
10/05/2011EP2370076A2 Pharmaceutical combination comprising a hsp 90 inhibitor and a mtor inhibitor
10/05/2011EP2370075A1 Use of geranyl-geranyl transferase in treating spinal cord lesions
10/05/2011EP2370074A1 Lipid composition for the treatment of skin problems in companion animals
10/05/2011EP2370073A1 Composition of amino acids for sublingual applying for enhanced skin integument repigmentation in vitiligo and method of its administration
10/05/2011EP2370072A1 Phytoestrogenic compositions for preventing or treating symptoms associated with menopause
10/05/2011EP2370071A1 Novel oxime derivatives of 3,5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
10/05/2011EP2370070A1 Phosphodiesterase type iii (pde iii) inhibitors or ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
10/05/2011EP2370069A1 Antioxidant compositions for soft oral tissue and methods of formulation and use there
10/05/2011EP2370067A1 Antiviral patch
10/05/2011EP2370065A1 Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin-ii antagonist and/or a diuretic
10/05/2011EP2370063A2 Flowable pharmaceutical depot
10/05/2011EP2370061A2 Pharmaceutical composition comprising ezetimibe and simvastatin
10/05/2011EP2370058A1 Liposomal composition for convection-enhanced delivery to the central nervous centre
10/05/2011EP2370057A1 Topical herbal formulation for treatment of acne and skin disorders
10/05/2011EP2370054A2 Contact lens drug delivery device
10/05/2011EP2370053A1 Novel powdered crystalline medicines for inhalation
10/05/2011EP2370043A1 Method and apparatus for packaging and dispensing pharmaceuticals
10/05/2011EP2369947A2 Beer and beer-based beverages and method of modification of polyphenols and silicon content in these beverages
10/05/2011EP2369930A1 Method for reducing blood pressure using inhibitors of plasma kallikrein
10/05/2011EP2369926A1 Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues
10/05/2011EP2369925A1 An l-arginine-based formulation for oral absorption
10/05/2011EP2369924A1 Nitrooxy cycloalkane derivatives
10/05/2011EP2297118B1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives as lxr modulators
10/05/2011EP2294070B1 New phenanthrylphenol linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof
1 ... 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 ... 7860